{"id":"https://openalex.org/W2739983108","doi":null,"title":"GABAPENTIN IS NEUROPROTECTIVE THROUGH GLUTAMATE RECEPTOR INDEPENDENT MECHANISMS IN STAUROSPORINEINDUCED APOPTOSIS OF CULTURED RAT","display_name":"GABAPENTIN IS NEUROPROTECTIVE THROUGH GLUTAMATE RECEPTOR INDEPENDENT MECHANISMS IN STAUROSPORINEINDUCED APOPTOSIS OF CULTURED RAT","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2739983108","mag":"2739983108"},"language":"en","primary_location":{"id":"mag:2739983108","doi":null,"is_oa":false,"landing_page_url":"https://link.springer.com/content/pdf/10.2478/s13380-013-0139-9.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046169195","display_name":"Victor Babe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Babe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108231315","display_name":"Carol Davila","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carol Davila","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035504241","display_name":"Bogdan Ovidiu Popescu","orcid":"https://orcid.org/0000-0003-4826-2598","observed_orcids":["https://orcid.org/0000-0003-4826-2598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bogdan Ovidiu Popescu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4826-2598","affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Radu Stoica","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Radu Stoica","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.82669997215271,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.82669997215271,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.06210000067949295,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.05460000038146973,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":1.0},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.949999988079071},{"id":"https://openalex.org/keywords/staurosporine-induced-apoptosis","display_name":"staurosporine-induced apoptosis","score":0.968999981880188},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":0.7799999713897705},{"id":"https://openalex.org/keywords/cerebellar-granule-cells","display_name":"cerebellar granule cells","score":0.9089999794960022},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.7319999933242798},{"id":"https://openalex.org/keywords/ampa-receptors","display_name":"AMPA receptors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/gaba","display_name":"GABA","score":0.7480000257492065},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.8889999985694885},{"id":"https://openalex.org/keywords/neuronal-cell-adhesion-molecule","display_name":"neuronal cell adhesion molecule","score":0.777999997138977},{"id":"https://openalex.org/keywords/synaptophysin","display_name":"synaptophysin","score":0.9459999799728394},{"id":"https://openalex.org/keywords/neuroplasticity","display_name":"neuroplasticity","score":0.9440000057220459}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.9112372398376465},{"id":"https://openalex.org/C160268369","wikidata":"https://www.wikidata.org/wiki/Q295251","display_name":"AMPA receptor","level":4,"score":0.7794105410575867},{"id":"https://openalex.org/C2780076171","wikidata":"https://www.wikidata.org/wiki/Q972076","display_name":"NBQX","level":5,"score":0.7595558166503906},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.7175417542457581},{"id":"https://openalex.org/C2779084600","wikidata":"https://www.wikidata.org/wiki/Q5957181","display_name":"Staurosporine","level":4,"score":0.6263161301612854},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6156049966812134},{"id":"https://openalex.org/C2781012912","wikidata":"https://www.wikidata.org/wiki/Q901117","display_name":"Excitotoxicity","level":4,"score":0.4990997314453125},{"id":"https://openalex.org/C189184402","wikidata":"https://www.wikidata.org/wiki/Q3454536","display_name":"Kainate receptor","level":5,"score":0.45812711119651794},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4518439769744873},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4444717466831207},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.43935173749923706},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.36251312494277954},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.352563738822937},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19544875621795654},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.18307426571846008},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.1756187081336975}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2739983108","doi":null,"is_oa":false,"landing_page_url":"https://link.springer.com/content/pdf/10.2478/s13380-013-0139-9.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W93647679","https://openalex.org/W1562796888","https://openalex.org/W1578485755","https://openalex.org/W1964288062","https://openalex.org/W1965829294","https://openalex.org/W1968723804","https://openalex.org/W1972130056","https://openalex.org/W1983031627","https://openalex.org/W1997544686","https://openalex.org/W2009989740","https://openalex.org/W2012940026","https://openalex.org/W2013961519","https://openalex.org/W2018528310","https://openalex.org/W2023462778","https://openalex.org/W2024380057","https://openalex.org/W2029529074","https://openalex.org/W2030298140","https://openalex.org/W2044492675","https://openalex.org/W2045180954","https://openalex.org/W2045497115","https://openalex.org/W2057743459","https://openalex.org/W2059787565","https://openalex.org/W2064208483","https://openalex.org/W2064572902","https://openalex.org/W2065143633","https://openalex.org/W2067245921","https://openalex.org/W2087281700","https://openalex.org/W2090603038","https://openalex.org/W2093917720","https://openalex.org/W2105640034","https://openalex.org/W2106096775","https://openalex.org/W2114918609","https://openalex.org/W2115438929","https://openalex.org/W2120703357","https://openalex.org/W2121429522","https://openalex.org/W2143834086","https://openalex.org/W2146972564","https://openalex.org/W2148210877","https://openalex.org/W2161276777","https://openalex.org/W2163740028","https://openalex.org/W2195324906","https://openalex.org/W2314162356","https://openalex.org/W2404424090","https://openalex.org/W2408884262"],"related_works":["https://openalex.org/W2073548557","https://openalex.org/W2066027170","https://openalex.org/W2090816040","https://openalex.org/W2141886377","https://openalex.org/W2039984268","https://openalex.org/W2061732619","https://openalex.org/W2373596895","https://openalex.org/W2621841546","https://openalex.org/W2089382485","https://openalex.org/W1818767073"],"abstract_inverted_index":{"The":[0],"anticonvulsants":[1],"that":[2,26,183],"are":[3,16],"currently":[4],"available":[5],"modulate":[6],"the":[7,24,163,173],"activity":[8],"of":[9,76,110,135,156,165,176,194],"neuronal":[10,166,177,195],"receptors":[11,35,58,78,114],"and":[12,71,103,145,191],"ion":[13],"channels,":[14],"which":[15,49,125,198],"equally":[17],"involved":[18],"in":[19,95,99],"apoptotic":[20],"pathways.":[21],"We":[22],"investigated":[23],"hypothesis":[25],"gabapentin":[27],"(GP),":[28],"an":[29],"anticonvulsant":[30],"without":[31,192],"effect":[32,134],"on":[33,137],"glutamate":[34,77],"acting":[36],"as":[37],"GABA":[38],"analog,":[39],"has":[40,50],"neuroprotective":[41,55,154,186],"properties.":[42],"For":[43,60],"comparison,":[44],"we":[45,63,72,181],"chose":[46],"topiramate":[47],"(TPM),":[48],"been":[51],"reported":[52],"to":[53],"be":[54],"via":[56],"AMPA":[57,113],"blockade.":[59],"this":[61],"purpose,":[62],"used":[64],"rat":[65],"cerebellar":[66],"granule":[67],"neuron":[68],"(CGN)":[69],"cultures":[70,97,140],"triggered":[73],"apoptosis":[74,105],"independent":[75,189],"with":[79,153],"staurosporine,":[80],"a":[81,201],"broad-spectrum":[82],"protein":[83],"kinase":[84],"inhibitor.":[85],"GP":[86,123,157,184],"at":[87],"therapeutic":[88],"range":[89],"concentration":[90,102],"significantly":[91],"increased":[92],"cell":[93,167],"viability":[94],"CGN":[96,139],"maintained":[98],"physiological":[100],"KCl":[101],"reversed":[104,127],"induced":[106],"by":[107,115,129,143,148],"staurosporine.":[108],"Blockade":[109],"NMDA":[111],"or":[112,117,150,158,170,172],"MK801":[116,149],"NBQX,":[118,144],"respectively,":[119],"did":[120,160],"not":[121,146,161],"alter":[122],"neuroprotection,":[124],"was":[126,141],"instead":[128],"GABA.":[130,151],"In":[131,179],"contrast,":[132],"protective":[133],"TPM":[136,159],"STS-treated":[138],"annihilated":[142],"altered":[147],"Treatments":[152],"concentrations":[155],"modify":[162],"expression":[164],"adhesion":[168],"molecule":[169],"synaptophysin":[171],"morphological":[174],"aspect":[175],"endings.":[178],"summary,":[180],"report":[182],"is":[185],"through":[187],"glutamate-receptor":[188],"mechanisms":[190],"alteration":[193],"plasticity":[196],"markers,":[197],"makes":[199],"it":[200],"possible":[202],"candidate":[203],"for":[204],"clinical":[205],"neuroprotection":[206],"trials.":[207]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-08-08T00:00:00"}